New & Noteworthy

October 2022

Bortezomib for Injection

Dr. Reddy's Laboratories Inc

Dr. Reddy’s Laboratories, a generics manufacturer, launches bortezomib for injection, the generic equivalent of Velcade (bortezomib) injection, following the approval of the US FDA. Dr. Reddy’s bortezomib for injection is supplied in a 3.5 mg per 10 mL single dose vial presentation for subcutaneous (SQ) or intravenous (IV) use.

Request More Information

Current Issue